Co-Authors
This is a "connection" page, showing publications co-authored by SANTIAGO VALDES and BRADY MOFFETT.
Connection Strength
0.908
-
"Second line medications" for supraventricular arrhythmias in children: In-hospital efficacy and adverse events during treatment initiation of sotalol and flecainide. J Cardiovasc Electrophysiol. 2021 08; 32(8):2207-2215.
Score: 0.196
-
Cardiac Arrest in Pediatric Patients Receiving Azithromycin. J Pediatr. 2017 03; 182:311-314.e1.
Score: 0.144
-
Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database. Cardiol Young. 2015 Aug; 25(6):1080-5.
Score: 0.123
-
Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015 Jan; 36(1):146-50.
Score: 0.122
-
Possible digoxin toxicity associated with concomitant ciprofloxacin therapy. Int J Clin Pharm. 2013 Oct; 35(5):673-6.
Score: 0.114
-
Amiodarone monitoring practices in pediatric hospitals in the United States. Pediatr Cardiol. 2013; 34(8):1762-6.
Score: 0.112
-
Analysis of adults with congenital heart disease presenting to pediatric emergency departments with arrhythmias. Congenit Heart Dis. 2017 Jul; 12(4):507-511.
Score: 0.037
-
Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. J Pediatr. 2015 Jan; 166(1):115-8.
Score: 0.031
-
Race contributes to beta-blocker efficacy in pediatric patients with arrhythmias. Pediatr Cardiol. 2014 Apr; 35(4):641-4.
Score: 0.029